The isocitrate dehydrogenase (IDH1) gene represents a recurrent mutation in GBM patients, which was associated with good prognostic outcomes compared to wild-type counterparts (TCGA-GBM cohort, log-rank p <0.0001, Figure S1C) (12). The gene discussed is IDH3A; the disease is glioblastoma.